A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. [electronic resource]
- Neurology Oct 2015
- 1383-91 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1526-632X
10.1212/WNL.0000000000002035 doi
Aged Aged, 80 and over Alzheimer Disease--blood Double-Blind Method Female Gastrointestinal Diseases--blood Humans Male Middle Aged Resveratrol Stilbenes--adverse effects